1. Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer


    Wei Liu et al, 2020, OncoTargets and Therapy CrossRef
  2. Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota
    Antonino Di Lorenzo et al, 2020, International Journal of Molecular Sciences CrossRef
  3. Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1
    Carolina M. Gorgulho et al, 2019, Frontiers in Immunology CrossRef
  4. Immunostimulatory Properties of Chemotherapy in Breast Cancer: From Immunogenic Modulation Mechanisms to Clinical Practice
    Jinguo Zhang et al, 2022, Frontiers in Immunology CrossRef
  5. Severe Radiation-Induced Lymphopenia Affects the Outcomes of Esophageal Cancer: A Comprehensive Systematic Review and Meta-Analysis
    Dongjun Dai et al, 2022, Cancers CrossRef
  6. Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death
    Joanna Kopecka et al, 2020, Cells CrossRef
  7. Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells
    Worawat Songjang et al, 2022, International Journal of Molecular Sciences CrossRef
  8. Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
    Bernardo Rapoport et al, 2019, International Journal of Molecular Sciences CrossRef
  9. Ivermectin Enhanced Antitumor Activity of Resiquimod in a Co-Loaded Squalene Emulsion
    Zhongkun Zhang et al, 2022, Journal of Pharmaceutical Sciences CrossRef
  10. High Mobility Group Box 1 in Human Cancer
    Bernardo L. Rapoport et al, 2020, Cells CrossRef
  11. Hyaluronic Acid Nanoparticles for Immunogenic Chemotherapy of Leukemia and T-Cell Lymphoma
    Vinu Krishnan et al, 2022, Pharmaceutics CrossRef
  12. Photothermal-Chemotherapy Integrated Nanoparticles with Tumor Microenvironment Response Enhanced the Induction of Immunogenic Cell Death for Colorectal Cancer Efficient Treatment
    Yayu Wen et al, 2019, ACS Applied Materials & Interfaces CrossRef
  13. Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
    David A. Bernal-Estévez et al, 2021, Frontiers in Immunology CrossRef
  14. Adjuvant Antitumor Immunity Contributes to the Overall Antitumor Effect of Pegylated Liposomal Doxorubicin (Doxil®) in C26 Tumor-Bearing Immunocompetent Mice
    Takuma Takayama et al, 2020, Pharmaceutics CrossRef
  15. Therapeutic Associations Comprising Anti-PD-1/PD-L1 in Breast Cancer: Clinical Challenges and Perspectives
    Fanny Ledys et al, 2021, Cancers CrossRef
  16. Novel Methods to Overcome Acquired Resistance to Immunotherapy
    Xianda Zhao et al, 2019, Current Applications for Overcoming Resistance to Targeted Therapies CrossRef
  17. Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
    Mohammad Hossein Kazemi et al, 2022, Frontiers in Immunology CrossRef
  18. Effectiveness and Safety of the Traditional Chinese Medicine Treatment (HuoxueHuayu Therapy) for Malignant Tumors: A Systematic Review and Meta-Analysis
    Zehui Chen et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
  19. Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity
    Sang-Soo Kim et al, 2022, Cancers CrossRef